In March 2017, the German parliament voted for the legalization of cannabis for medicinal purposes. This meant that many changes had to be made within its legislation. A year on much has changed in this respect. Moreover, other EU member states have been closely monitoring Germany’s progress in the legalization of medical cannabis and are now following suit.

The legalization process in Germany has been strictly performed and controlled by the government. Law firms, on the other hand, are responsible for advising companies, who want to import, cultivate and distribute cannabis in Germany.

Dentons is one of the top 10 global law firms and present in over 50 countries. For the past few years, Peter and his team have been monitoring the legalization process for medical cannabis closely. They have been watching the developments in German legislation and the pharmaceutical market and advised and informed their clients on regulatory issues of import and future cultivation of cannabis in Germany.

The legalization of cannabis for medical use has experienced a widespread wave of interest and support in Europe. Why is this topic becoming so important now, within governments and the scientific community?

Read the full article at Labiotech